About Dr. Parrish
Special Expertise
Musculoskeletal disorders in patients with HIV/AIDSViral infections and autoimmune disorders
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending Rheumatologist, Hospital for Special SurgeryDirector, Mechanisms of Disease Course in Rheumatology, Hospital for Special Surgery
Director, Internal Medicine Residency Training Program, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Certifications
Internal Medicine
Rheumatology
Awards
Castle Connolly Top Doctor, 20 Years
Castle Connolly Top Doctors in New York Metro Area, 2002-2022
New York Magazine: Top Doctors, 2019-2022
Education
MD, Bowman Gray School of MedicineResidency
Columbia-Presbyterian Hospital, New YorkFellowship
Columbia-Presbyterian Hospital, New YorkState Licensure
New York
Languages
EnglishFor My Patients
Publications by Dr. Parrish
Patient Education
Selected Journal Articles
Research
Clinical Trials / Research Studies
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 11, 2024, Dr. Parrish reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.